Evidence map›Paper›PMID 41254440›Full record

ArticleThe AAPS journal2025

A Machine Learning-Empowered Quantitative Structure-Activity Relationship Model for Predicting the Plasma Half-life of Drugs in Dogs.

Xue Wu, Pei-Yu Wu, Wei-Chun Chou, Lisa A Tell, Zhoumeng Lin

Abstract read
PubMed Publisher
In one paragraph

Article in The AAPS journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Xue WuDepartment of Environmental and Global Health, College of Public Health and Health Professions, University of Florida, 2187 Mowry Road, Gainesville, Florida, 32611, USA.ORCID 0009-0008-2492-7368
Pei-Yu WuDepartment of Environmental and Global Health, College of Public Health and Health Professions, University of Florida, 2187 Mowry Road, Gainesville, Florida, 32611, USA.ORCID 0000-0002-7196-649X
Wei-Chun ChouDepartment of Environmental Sciences, College of Natural and Agricultural Sciences, University of California, Riverside, California, 92521, USA.ORCID 0000-0003-3355-6921
Lisa A TellDepartment of Medicine and Epidemiology, School of Veterinary Medicine, University of California-Davis, Davis, California, 95616, USA.ORCID 0000-0003-1823-7420
Zhoumeng LinDepartment of Environmental and Global Health, College of Public Health and Health Professions, University of Florida, 2187 Mowry Road, Gainesville, Florida, 32611, USA. linzhoumeng@ufl.edu.ORCID 0000-0002-8731-8366

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Understanding a drug's plasma half-life is essential in guiding dosage regimens and optimizing therapeutic outcomes, particularly in the early stages of drug development. By using published pharmacokinetic data from Food Animal Residue Avoidance Databank, we collected 560 data points of plasma half-lives for different drugs in dogs following intravenous administration. The dataset was then preprocessed and the mean elimination half-life for each drug was selected in the final clean dataset for model training and testing. Five types of chemical descriptors and four types of supervised machine learning (ML) algorithms were employed to build ML-empowered Quantitative Structure-Activity Relationship (QSAR) models. Model performances were assessed by determination coefficient (R

Indexed as

Machine LearningModels, BiologicalQuantitative Structure-Activity RelationshipAnimalsDogsHalf-LifePharmaceutical PreparationsPharmaceutical Preparationsmachine learningNew Approach Methodologies (NAMs)pharmacokineticsplasma half-lifeQuantitative Structure–Activity Relationship (QSAR) Modeling

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.